177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer.

التفاصيل البيبلوغرافية
العنوان: 177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer.
المؤلفون: Perrone E; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany; Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Rome, Italy. elisabetta.perrone01@icatt.it., Ghai K; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany., Eismant A; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany., Konz K; Department of Endocrinology, Deutsche Klinik für Diagnostik, Wiesbaden, Germany., Baum RP; CURANOSTICUM Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
المصدر: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2024 Jul 05; Vol. 63, pp. 557-562. Date of Electronic Publication: 2024 Jul 05.
نوع المنشور: Case Reports; Letter
اللغة: English
بيانات الدورية: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2024- : [Uppsala, Sweden] : Medical Journals Sweden AB
Original Publication: Stockholm, Sweden : Acta Oncologica, [1987-
مواضيع طبية MeSH: Adrenal Gland Neoplasms*/secondary , Adrenal Gland Neoplasms*/radiotherapy , Lutetium*/therapeutic use , Radiopharmaceuticals*/therapeutic use, Aged ; Humans ; Male ; Dipeptides/therapeutic use ; Heterocyclic Compounds, 1-Ring/therapeutic use ; Prostate-Specific Antigen ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/pathology ; Radioisotopes/therapeutic use
المشرفين على المادة: 0 (Dipeptides)
0 (Heterocyclic Compounds, 1-Ring)
5H0DOZ21UJ (Lutetium)
BRH40Y9V1Q (Lutetium-177)
0 (Pluvicto)
EC 3.4.21.77 (Prostate-Specific Antigen)
0 (Radioisotopes)
0 (Radiopharmaceuticals)
تواريخ الأحداث: Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240713
رمز التحديث: 20240713
DOI: 10.2340/1651-226X.2024.40017
PMID: 38967321
قاعدة البيانات: MEDLINE
الوصف
تدمد:1651-226X
DOI:10.2340/1651-226X.2024.40017